Senior insider sale
See Remarks at ARCUTIS BIOTHERAPEUTICS, INC. — senior position signals high conviction
$8.55M
341.98K shares
What this filing means
EDWARDS LARRY TODD plans to sell 341.98K shares of ARCUTIS BIOTHERAPEUTICS, INC. valued at approximately $8.55M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/16/2026ACC: 0001628280-26-062242
Officer· See Remarks
Since Feb 2026
341.98K
Shares to sell
$8.55M
Approx. market value
341.98K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months4
Stock Option Exercise
Cash
2/27/2026
8.02KStock Option Exercise
Cash
2/28/2025
50.29KStock Option Exercise
Cash
1/12/2024
113.67KStock Option Exercise
Cash
9/27/2023
170KTotal acquired341.98K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/27/2026 | Stock Option Exercise Cash | 8.02K | — |
2/28/2025 | Stock Option Exercise Cash | 50.29K | — |
1/12/2024 | Stock Option Exercise Cash | 113.67K | — |
9/27/2023 | Stock Option Exercise Cash | 170K | — |
| Total | 341.98K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
341.98K
Market value
$8.55M
9/16/2026
Total
Units
341.98K
Value
$8.55M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/16/2026 | 341.98K | $8.55M | NASDAQ | Planned |
| Total | 341.98K | $8.55M | ||